moxonidine has been researched along with Epistaxis in 1 studies
moxonidine: structure given in first source
Epistaxis: Bleeding from the nose.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Moxonidine, a new imidazoline II receptor agonist was evaluated in patients with essential hypertension." | 9.09 | Safety and efficacy of moxonidine in mild to moderate hypertension. ( Jain, S; Kumari, S; Malhotra, P; Varma, S, 2001) |
| "Moxonidine, a new imidazoline II receptor agonist was evaluated in patients with essential hypertension." | 5.09 | Safety and efficacy of moxonidine in mild to moderate hypertension. ( Jain, S; Kumari, S; Malhotra, P; Varma, S, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jain, S | 1 |
| Malhotra, P | 1 |
| Kumari, S | 1 |
| Varma, S | 1 |
1 trial available for moxonidine and Epistaxis
| Article | Year |
|---|---|
Safety and efficacy of moxonidine in mild to moderate hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Epistaxis; Female; Humans; Hypertension; Imida | 2001 |